Evidence map›Paper›PMID 25461718›Full record

ReviewCurrent opinion in chemical biology2015

In vivo continuous directed evolution.

Ahmed H Badran, David R Liu

Abstract readReview
In one paragraph

Review in Current opinion in chemical biology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Engineering of methionine-auxotrophMetabolic engineering communications · 2024
    Article
  5. Article
  6. Review
  7. Article
  8. Evolution and synthetic biology.Current opinion in microbiology · 2023
    Review
  9. Review
  10. Virus-assisted directed evolution of biomolecules.Current opinion in chemical biology · 2023
    Review
  11. Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Ahmed H BadranDepartment of Chemistry and Chemical Biology, Harvard University, Cambridge, MA 02138, United States; Howard Hughes Medical Institute, Harvard University, Cambridge, MA 02138, United States.
David R LiuDepartment of Chemistry and Chemical Biology, Harvard University, Cambridge, MA 02138, United States; Howard Hughes Medical Institute, Harvard University, Cambridge, MA 02138, United States. Electronic address: drliu@fas.harvard.edu.

Funding

Expanding the Scope of Protein EvolutionR01GM065400 · NIGMS · HARVARD UNIVERSITY · PI LIU, DAVID R · 2002 to 2010
$2.5M
Howard Hughes Medical InstituteNIGMS NIH HHS R01 GM065400
6 · The paper itself

Abstract

The development and application of methods for the laboratory evolution of biomolecules has rapidly progressed over the last few decades. Advancements in continuous microbe culturing and selection design have facilitated the development of new technologies that enable the continuous directed evolution of proteins and nucleic acids. These technologies have the potential to support the extremely rapid evolution of biomolecules with tailor-made functional properties. Continuous evolution methods must support all of the key steps of laboratory evolution - translation of genes into gene products, selection or screening, replication of genes encoding the most fit gene products, and mutation of surviving genes - in a self-sustaining manner that requires little or no researcher intervention. Continuous laboratory evolution has been historically used to study problems including antibiotic resistance, organismal adaptation, phylogenetic reconstruction, and host-pathogen interactions, with more recent applications focusing on the rapid generation of proteins and nucleic acids with useful, tailor-made properties. The advent of increasingly general methods for continuous directed evolution should enable researchers to address increasingly complex questions and to access biomolecules with more novel or even unprecedented properties.

Indexed as

AnimalsBacteriaCell Culture TechniquesDirected Molecular EvolutionEquipment DesignHumansViruses

Identifiers

PMID25461718
PMCPMC4308500

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.